Free Trial

305,277 Shares in Nutrien Ltd. (NYSE:NTR) Purchased by Guardian Partners Inc.

Nutrien logo with Basic Materials background
Remove Ads

Guardian Partners Inc. bought a new stake in Nutrien Ltd. (NYSE:NTR - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 305,277 shares of the company's stock, valued at approximately $14,606,000. Nutrien makes up about 1.5% of Guardian Partners Inc.'s investment portfolio, making the stock its 18th largest holding. Guardian Partners Inc. owned about 0.06% of Nutrien as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Nutrien during the third quarter worth about $150,181,000. ARGA Investment Management LP increased its position in shares of Nutrien by 25.7% during the 4th quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company's stock worth $270,396,000 after purchasing an additional 1,236,671 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of Nutrien by 78.8% during the 3rd quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company's stock worth $121,271,000 after purchasing an additional 1,100,000 shares in the last quarter. Silchester International Investors LLP boosted its holdings in shares of Nutrien by 9.5% in the 4th quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company's stock valued at $523,268,000 after buying an additional 1,009,895 shares during the last quarter. Finally, Pacific Heights Asset Management LLC grew its stake in shares of Nutrien by 462.1% in the fourth quarter. Pacific Heights Asset Management LLC now owns 815,000 shares of the company's stock valued at $36,471,000 after buying an additional 670,000 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

Several analysts have issued reports on the stock. Raymond James raised shares of Nutrien from a "market perform" rating to an "outperform" rating and upped their price target for the stock from $58.00 to $60.00 in a research report on Tuesday, December 3rd. The Goldman Sachs Group began coverage on shares of Nutrien in a report on Thursday, March 13th. They issued a "sell" rating and a $53.00 target price on the stock. UBS Group raised their target price on shares of Nutrien from $53.00 to $54.00 and gave the company a "neutral" rating in a research note on Thursday, February 20th. Wells Fargo & Company boosted their price target on Nutrien from $53.00 to $56.00 and gave the stock an "equal weight" rating in a research report on Friday, February 21st. Finally, Piper Sandler raised their price objective on Nutrien from $58.00 to $63.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $60.00.

Get Our Latest Analysis on Nutrien

Nutrien Stock Performance

NTR stock traded up $0.38 during trading hours on Thursday, hitting $50.89. 1,482,034 shares of the stock were exchanged, compared to its average volume of 1,970,820. Nutrien Ltd. has a 12 month low of $43.70 and a 12 month high of $60.87. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $24.90 billion, a P/E ratio of 37.15, a P/E/G ratio of 1.19 and a beta of 0.81. The company has a 50-day simple moving average of $51.62 and a two-hundred day simple moving average of $48.94.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 EPS for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). The business had revenue of $5.08 billion for the quarter, compared to the consensus estimate of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. On average, analysts forecast that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 31st will be given a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 4.28%. The ex-dividend date is Monday, March 31st. Nutrien's dividend payout ratio is currently 159.12%.

Nutrien Company Profile

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Stories

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads